ONO PHARMA USA Appoints David Trexler as Chief Commercial Officer to Strengthen U.S. Leadership
Mr. Trexler to lead the commercial infrastructure for tirabrutinib and other compounds in oncology pipeline
CAMBRIDGE, Mass., Sept. 28, 2021 -- (Healthcare Sales & Marketing Network) -- ONO PHARMA USA, INC. (President and CEO, Kunihiko Ito, "OPUS&... Biopharmaceuticals, Personnel ONO PHARMA USA, tirabrutinib
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news